Fennec Pharmaceuticals is a biopharmaceutical company focused on its product candidate, PEDMARK® (sodium thiosulfate injection), which is used to reduce the risk of ototoxicity associated with cisplatin in pediatric patients one month of age and older with localized, non-metastatic solid tumors. Co. has established Fennec HEARS™, a single source program designed to connect PEDMARK® patients to both patient financial and product access support. The program provides assistance and resources, regardless of insurance type, that can address co-pays or lack of coverage when certain eligibility requirements are met. We show 26 historical shares outstanding datapoints in our FENC shares outstanding history coverage, used to compute FENC market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing FENC market cap history over the course of time is important for investors
interested in comparing FENC's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of FENC versus a peer is one thing; comparing
FENC market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like FENC can fluctuate over the course of history.
With this page we aim to empower investors researching FENC by allowing them to research the FENC market cap history. |
Free FENC Email Alerts:
Video: The Importance of Market Cap
